One-year budget impact of InTandem™: a novel neurorehabilitation system for individuals with chronic stroke walking impairment.

ABSTRACT: Aim: Chronic stroke walking impairment is associated with high healthcare resource utilization (HCRU) costs. InTandem™ is a neurorehabilitation system that autonomously delivers a rhythmic auditory stimulation (RAS)-based intervention for the at-home rehabilitation of walking impairment in adults in the chronic phase of stroke recovery. This study was conducted to estimate the budget impact of InTandem in comparison with currently available intervention strategies for improvement of gait/ambulation in individuals with chronic stroke walking impairment. Methods & materials: A budget impact analysis (BIA) for InTandem was conducted based on a 1-million-member US third-party payer perspective over a 1-year time horizon. Key inputs for the budget impact model were: costs for each

SUBMITTER: Smayda KE 

PROVIDER: S-EPMC11426287 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature